Literature DB >> 2895584

A grandpaternally derived de novo deletion within Xp21 initially presenting in carrier females diagnosed as Kugelberg-Welander syndrome.

S Wood1, R J Shukin, B C McGillivray, P N Ray, R G Worton.   

Abstract

We report on two sisters with a history of muscle weakness and an electromyogram (EMG) diagnosis of Kugelberg-Welander syndrome (KWS) or juvenile spinal muscular atrophy. A half-brother to these women was diagnosed to have Duchenne muscular dystrophy (DMD). Using molecular probes, we identified a deletion within Xp21 in this isolated case of DMD. Sequences detected by pXJ1.1 are deleted, while fragments detected by pERT87 are intact. Both of these probes are derived from the DMD locus. We have shown that the affected sisters share with their half-brother DNA markers that are linked to the DMD gene and inherited from their maternal grandfather. Dosage analysis of Southern blots show monosomy for pXJ1.1, which has allowed us to determine carrier status within this family and to show that the half-sisters are manifesting DMD carriers.

Entities:  

Mesh:

Year:  1988        PMID: 2895584     DOI: 10.1002/ajmg.1320290225

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Familial 5q11.2----q13.3 segmental duplication cosegregating with multiple anomalies, including schizophrenia.

Authors:  B C McGillivray; A S Bassett; S Langlois; T Pantzar; S Wood
Journal:  Am J Med Genet       Date:  1990-01

2.  Brother/sister pairs affected with early-onset, progressive muscular dystrophy: molecular studies reveal etiologic heterogeneity.

Authors:  U Francke; B T Darras; J H Hersh; B O Berg; R G Miller
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

3.  Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis.

Authors:  P A Ward; J F Hejtmancik; J A Witkowski; L L Baumbach; S Gunnell; J Speer; P Hawley; U Tantravahi; C T Caskey
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.